CAS RN: 2040295-03-0
PLX3397 HCl
Product Availability
Choose a grade to view its available package options.
5 package records4 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260125 |
5mg / 10mg |
Out of stock |
| 5-7 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250710 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251219 |
250mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260320 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260514 |
50mg |
In stock |
Shanghai | | Inquiry |
-
Product code:
starshine_CAS2040295-03-0
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
2040295-03-0 / 5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]pyridin-2-amine;hydrochloride
Standard CAS: 2040295-03-0
Multi CAS: No
Basic Information
CAS
2040295-03-0
Multi CAS
No
Molecular Formula
C20H16Cl2F3N5
Molecular Weight
454.300000
Exact Mass
453.073485
SMILES
C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F.Cl
InChI
InChI=1S/C20H15ClF3N5.ClH/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24;/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29);1H
InChIKey
CJLUYLRKLUYCEK-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
30
Aromatic heavy atom count
21
Fraction Csp3
0.15
Rotatable bonds
5
H-bond acceptors
4
H-bond donors
2
Molar refractivity
111.96
TPSA
66.49
LogP / Solubility
WLOGP
5.65
MLOGP
5
XLogP3
5.65
Consensus LogP
5.43
Log S (ESOL)
-6.4
Class (ESOL)
Insoluble
Log S (Ali)
-7.36
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.9
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.48
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3